Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

about

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

Item

http://www.wikidata.org/entity/Q52640514

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@en

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@nl

type

Item

label

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@en

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@nl

prefLabel

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@en

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@nl

P1476

Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge.

@en

P2093

Allison Jun

http://www.w3.org/2001/XMLSchema#string

Grace Magedman

http://www.w3.org/2001/XMLSchema#string

Michelle Chilvers Murphy

http://www.w3.org/2001/XMLSchema#string

Tina Lee

http://www.w3.org/2001/XMLSchema#string

Winifred Stockton

http://www.w3.org/2001/XMLSchema#string

Yanjun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.

The burden of respiratory syncytial virus infection in young children

The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists.

Evaluation of a novel web-based prior approval application for palivizumab prophylaxis of respiratory syncytial virus in a state Medicaid program.

Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab.

Compliance with RSV prophylaxis: Global physicians' perspectives.

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.

The effect of an interventional program on adherence to the american academy of pediatrics guidelines for palivizumab prophylaxis.

P31

scholarly article

P356

10.1097/INF.0000000000001999

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29570593

http://www.w3.org/2001/XMLSchema#string

P932

6150837

http://www.w3.org/2001/XMLSchema#string